Cargando…
Narrow-Spectrum Antibacterial Agents—Benefits and Challenges
The number of antibacterial agents in clinical and preclinical development possessing activity against a narrow spectrum of bacterial pathogens is increasing, with many of them being nontraditional products. The key value proposition hinges on sparing antibiotic use and curtailing the emergence of r...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400354/ https://www.ncbi.nlm.nih.gov/pubmed/32708925 http://dx.doi.org/10.3390/antibiotics9070418 |